NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference -October 19, 2023 at 08:01 am EDT
SANTA ANA, Calif., Oct. 19, 2023 -- NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK...